Hall Laurie J Trustee Abb Vie Inc. Transaction History

Hall Laurie J Trustee

$305 Million
Q4 2024

A detailed history of Hall Laurie J Trustee transactions in Abb Vie Inc. stock. As of the latest transaction made, Hall Laurie J Trustee holds 15,510 shares of ABBV stock, worth $3.04 Million. This represents 0.9% of its overall portfolio holdings.

Number of Shares

15,510

Previous 15,670 1.02%

Holding current value

$3.04 Million

Previous $3.09 Million 10.92%

% of portfolio

0.9%

Previous 0.98%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 16, 2025	SELL	$164.99 - $203.87 $26,398 - $32,619	-160 Reduced 1.02%	15,510 $2.76 Million
Q2 2024 Jul 22, 2024	SELL	$154.79 - $180.76 $9,287 - $10,845	-60 Reduced 0.38%	15,670 $2.69 Million
Q1 2024 Apr 23, 2024	SELL	$159.82 - $182.1 $442,701 - $504,417	-2,770 Reduced 14.97%	15,730 $2.86 Million
Q3 2023 Oct 12, 2023	SELL	$133.59 - $154.65 $22,042 - $25,517	-165 Reduced 0.88%	18,500 $2.76 Million
Q2 2023 Jul 14, 2023	SELL	$132.51 - $164.9 $16,563 - $20,612	-125 Reduced 0.67%	18,665 $2.52 Million
Q4 2022 Jan 11, 2023	SELL	$138.31 - $165.87 $41,493 - $49,761	-300 Reduced 1.57%	18,790 $3.04 Million
Q2 2022 Jul 06, 2022	SELL	$137.62 - $174.96 $25,459 - $32,367	-185 Reduced 0.96%	19,090 $2.92 Million
Q1 2022 Apr 06, 2022	SELL	$131.98 - $163.75 $39,594 - $49,125	-300 Reduced 1.53%	19,275 $3.13 Million
Q3 2021 Oct 04, 2021	SELL	$106.4 - $120.78 $111,720 - $126,819	-1,050 Reduced 5.09%	19,575 $2.11 Million
Q2 2021 Jul 07, 2021	SELL	$105.21 - $117.21 $10,521 - $11,721	-100 Reduced 0.48%	20,625 $2.32 Million
Q1 2021 Apr 15, 2021	SELL	$102.3 - $112.62 $63,426 - $69,824	-620 Reduced 2.9%	20,725 $2.24 Million
Q4 2020 Jan 25, 2021	SELL	$80.49 - $108.67 $18,110 - $24,450	-225 Reduced 1.04%	21,345 $2.29 Million
Q3 2020 Oct 09, 2020	SELL	$85.91 - $100.83 $133,847 - $157,093	-1,558 Reduced 6.74%	21,570 $1.89 Million
Q4 2019 Feb 12, 2020	SELL	$72.13 - $90.25 $45,658 - $57,128	-633 Reduced 2.66%	23,128 $2.05 Million
Q3 2019 Oct 25, 2019	SELL	$62.98 - $75.72 $209,408 - $251,769	-3,325 Reduced 12.28%	23,761 $1.8 Million
Q2 2019 Aug 01, 2019	SELL	$65.7 - $83.98 $1 Million - $1.28 Million	-15,221 Reduced 35.98%	27,086 $1.97 Million
Q1 2019 May 02, 2019	SELL	$77.14 - $90.79 $107,996 - $127,106	-1,400 Reduced 3.2%	42,307 $3.41 Million
Q4 2018 Feb 14, 2019	SELL	$77.85 - $96.01 $358,732 - $442,414	-4,608 Reduced 9.54%	43,707 $3.49 Million
Q3 2018 Oct 30, 2018	SELL	$88.91 - $98.84 $22,227 - $24,710	-250 Reduced 0.51%	48,315 $4.57 Million
Q2 2018 Aug 01, 2018	SELL	$89.78 - $106.23 $175,071 - $207,148	-1,950 Reduced 3.86%	48,565 $4.5 Million
Q1 2018 May 10, 2018	SELL	$92.01 - $123.21 $140,775 - $188,511	-1,530 Reduced 2.94%	50,515 $4.78 Million
Q4 2017 Jan 30, 2018	SELL	$89.56 - $98.21 $12,538 - $13,749	-140 Reduced 0.27%	52,045 $5.03 Million
Q3 2017 Oct 02, 2017	SELL	$69.85 - $89.22 $698 - $892	-10 Reduced 0.02%	52,185 $0
Q2 2017 Aug 22, 2017	BUY	N/A	52,195	52,195 $0

Others Institutions Holding ABBV

# of Institutions

4,082

Shares Held

1.28B

Call Options Held

16.7M

Put Options Held

15M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $347B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hall Laurie J Trustee, based on Form 13F filings with the SEC.

News

Stay updated on Hall Laurie J Trustee with notifications on news.

Account

Hall Laurie J Trustee Abb Vie Inc. Transaction History